Misleading drug advertising [5]

Canadian Journal of Psychiatry

Volumn 46, Issue 7, 2001, Pages 660-661

  Hoaken, P C S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HALOPERIDOL; RISPERIDONE; VENLAFAXINE; ZIPRASIDONE;

DRUG INDUSTRY; DRUG MARKETING; EXTRAPYRAMIDAL SYMPTOM; HUMAN; LETTER; LONG QT SYNDROME;

EID: 0035150113     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370104600722     Document Type: Letter

References (6)

1. Aventyl - A new dimension in the adjunctive treatment of depression; Tofranil an aid to psychotherapy
2. Is schizophrenia treatment hampered by weight gain
3. The pharmacology of weight gain with antipsychotics
4. Does fast dissociation from the dopamine D2 receptor explain the reaction of atypical antipsychotics? A new hypothesis